Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection

Pathology Research and Practice

Volumn 195, Issue 4, 1999, Pages 243-246

  Faller, Gerhard ^a   Winter, Matthias ^b   Steininger, Helmuth ^b   Lehn, Norbert ^b   Meining, Alexander ^b   Bayerdörffer, Ekkehard ^b   Kirchner, Thomas ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

Antigastric autoantibodies; Eradication therapy; Gastric atrophy; H. pylori gastritis

Indexed keywords

AMOXICILLIN; AUTOANTIBODY; OMEPRAZOLE; PARIETAL CELL ANTIBODY;

ADULT; AGED; ARTICLE; ATROPHY; BACTERIAL INFECTION; CONTROLLED STUDY; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; LABORATORY; MAJOR CLINICAL STUDY; SERUM; STOMACH MUCOSA; STOMACH PARIETAL CELL;

EID: 0032916965     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(99)80041-7     Document Type: Article

References (13)

1. Annibale B, Marignani M, Azzoni C, D'Ambra G, Caruana P, D'Adda T, Delle Fave G, Bordi C (1997) Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 2: 57-64
2. Appelmelk BJ, Faller G, Claeys D, Kirchner T, Vandenbroucke-Grauls CM (1998) Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today 19: 296-299
3. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 115: 340-347
4. Faller G, Steininger H, Appelmelk B, Kirchner T (1998) Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis. J Clin Pathol 51: 244-245
5. Faller G, Steininger H, Eck M, Hensen J, Hahn EG, Kirchner T (1996) Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch 427: 483-486
6. Faller G, Steininger H, Kränzlein J, Maul H, Kerkau T, Hensen J, Hahn EG, Kircher T (1997) Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 41: 619-623
7. Faller G, Winter M, Steininger H, Konturek P, Konturek SJ, Kirchner T (1998) Antigastric autoantibodies and gastric secretory function in Helicobacter pylori-infected patients with duodenal ulcer and non-ulcer dyspepsia. Scand J Gastroenterol 33: 276-282
8. Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Porro GB (1997) Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer. Am J Gastroenterol 92: 1844-1848
9. Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A, Cesari P, Graffeo M, Vaira D, Franzin G (1996) Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111: 655-665
10. Oberhuber G, Wuendisch T, Rapel S, Stolte M (1998) Significant improvement of atrophy after eradication therapy in atrophic body gastritis. Path Res Pract 194: 609-613
11. Steininger H, Faller G, Dewald E, Brabletz T, Jung A, Kirchner T (1998) Apoptosis in chronic gastritis and its correlation with antigastric autoantibodies. Virchows Arch 433: 13-18
12. Tucci A, Biasco G, Paparo GF (1997) Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 336: 957-958
13. van der Hulst RW, van der Ende A, Dekker FW, Ten Kate FJ, Weel JF, Keller JJ, Kruizinga SP, Dankert J, Tytgat GN (1997) Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year followup study. Gastroenterology 113: 25-30